NYSE: CICigna Group Stock
$294.34+4.90 (+1.69%)
Updated Sep 25, 2023
CI Price
$294.34
Fair Value Price
N/A
Market Cap
$87.12B
52 Week Low
$240.50
52 Week High
$340.11
P/E
13.23x
P/B
1.92x
P/S
0.45x
PEG
1.15x
Dividend Yield
1.63%
Revenue
$186.13B
Earnings
$6.65B
Gross Margin
12.6%
Operating Margin
5.11%
Profit Margin
3.6%
Debt to Equity
2.3
Operating Cash Flow
$13B
Beta
0.94
Next Earnings
Nov 2, 2023
Ex-Dividend
N/A
Next Dividend
N/A
CI Overview
Cigna Corporation is a managed healthcare and insurance company. It provides medical, dental, disability, life and accident insurance, primarily through employer-sponsored plans. Its Evernorth segment provides pharmacy, benefits management, care delivery and management, and intelligence solutions to health plans, employers, government organizations, and health care providers. Cigna was founded in 1982 and is headquartered in Bloomfield, CT.
Zen Score
–
Industry Average (35)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how CI scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CI ($294.34) is trading above its intrinsic value of $187.83, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CI is good value based on its earnings relative to its share price (13.23x), compared to the US market average (14.28x)
P/E vs Market Valuation
CI is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more CI due diligence checks available for Premium users.
Be the first to know about important CI news, forecast changes, insider trades & much more!
CI News
Valuation
CI price to earnings (PE)
For valuing profitable companies with steady earnings
Company
13.23x
Industry
21.15x
Market
14.28x
CI is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
CI is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
CI price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.92x
Industry
3.09x
CI is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
CI price to earnings growth (PEG)
For valuing profitable companies with growth potential
CI is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
CI's financial health
Profit margin
Revenue
$48.6B
Net Income
$1.5B
Profit Margin
3%
CI's Earnings (EBIT) of $9.51B... subscribe to Premium to read more.
Interest Coverage Financials
CI's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$150.1B
Liabilities
$104.5B
Debt to equity
2.3
CI's short-term liabilities ($47.35B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CI's long-term liabilities ($57.18B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CI's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
CI's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$2.5B
Investing
-$414.0M
Financing
-$435.0M
CI's operating cash flow ($12.90B)... subscribe to Premium to read more.
Debt Coverage Financials
CI vs Healthcare Plan Stocks
Cigna Group Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.